GeneDx Holdings Corp vs YieldMax Universe Fund of Option Income ETFs — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while YieldMax Universe Fund of Option Income ETFs trades at $7.72. The key difference: GeneDx Holdings Corp is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| WGS | YMAX | |
|---|---|---|
Market Cap | $1.80B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $167.51 | $14.00 |
52-Week Low | $34.51 | $7.51 |
Enterprise Value | $1.80B | — |
Trailing returns across standard periods
Latest headlines on both assets
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →